Finanzen von Cardio Diagnostics Holdings Inc (CDIO)CDIOCardio Diagnostics Holdings Inc

Evaluating the bottom line, Cardio Diagnostics Holdings Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -27950.50%, while the net margin is -28012.46%. These profitability ratios, combined with a Return on Equity (ROE) of -75.44%, provide a clear picture of how effectively CDIO converts its operational activities into shareholder value.

In the context of the broader market, CDIO competes directly with industry leaders such as NVNO and VNRX. With a market capitalization of $4.89M, it holds a significant position in the sector. When comparing efficiency, CDIO's gross margin of 100.00% stands against NVNO's N/A and VNRX's 100.00%. Such benchmarking helps identify whether Cardio Diagnostics Holdings Inc is trading at a premium or discount relative to its financial performance.

Cardio Diagnostics has shown a gross margin of 100% across recent quarters, indicating that it retains all revenue as gross profit. However, it has consistently reported negative net income, with a net margin of -28,012.46% in Q2 2026. The company has a current ratio of 17.15, suggesting it can cover its short-term liabilities, but the overall financial health is concerning due to ongoing losses.